+1 (817) 546-4770

EMA Panel Backs Uplizna for Neuromyelitis Optica

Academic Anxiety?

Get an original paper within hours and nail the task

156 experts online

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of the immunosuppressant inebilizumab (Uplizna, Horizon Therapeutics) for adults with neuromyelitis optica spectrum disorder (NMOSD) who are anti-aquaporin 4 immunoglobulin G (AQP4-IgG) seropositive.NMOSD is a rare, severely disabling, complement-mediated autoimmune neuroinflammatory disease of the central nervous system, characterized by devastating and unpredictable relapses that can cause immediate and irreversible damage.webmd.ads2.defineAd({id:’ads-pos-1122′,pos: 1122});Inebilizumab, which had orphan drug designation, binds to the B cell-specific surface antigen CD19, leading to a profound depletion of B cells, which are believed to play a central role in the pathogenesis of NMOSD.The drug can help reduce the risk of attacks in AQP4-IgG seropositive NMOSD. The most common side effects are urinary tract infections, joint pain, and reduction of immunoglobulins levels.

webmd.ads2.defineAd({id:’ads-pos-520′,pos: 520});Once approved in Europe, inebilizumab will be available as a 100-mg concentrate for solution for infusion.

webmd.ads2.defineAd({id:’ads-pos-1520′,pos: 1520});Inebilizumab should be prescribed by physicians experienced in the treatment of NMOSD and with access to appropriate medical support to manage potential severe reactions such as serious infusion-related reactions, the EMA said.Detailed recommendations for the use of inebilizumab will be described in the summary of product characteristics (SmPC), which will be published in the European public assessment report (EPAR) and made available in all official European Union languages after marketing authorization has been granted by the European Commission. For more Medscape Neurology news, join us on Facebook and Twitter.

webmd.ads2.defineAd({id:’ads-pos-141′,pos: 141});


Credits:Lead Image: Horizon Therapeutics

Medscape Medical News © WebMD, LLC Heartwire © WebMD, LLC WebMD Health News © WebMD, LLC Reuters Health Information © Send comments and news tips to news@medscape.net.

Cite this: EMA Panel Backs Uplizna for Neuromyelitis Optica – Medscape – Nov 15, 2021.


id: ‘ads-pos-904’,
pos: 904

id: ‘ads-pos-906’,
pos: 906

id: ‘ads-pos-907’,
pos: 907

Need an essay written specifically to meet your requirements?

Choose skilled experts on your subject and get an original paper within your deadline

156 experts online

Your time is important. Let us write you an essay from scratch

Tips and Tricks from our Blog

11174 Introduction To Management

Free Samples 11174 Introduction To Management .cms-body-content table{width:100%!important;} #subhidecontent{ position: relative; overflow-x: auto; width: 100%;} 11174 Introduction

Read More »